Damora Therapeutics, Inc.
USD26.30
+2.09 (+8.63%)
CEO
Jennifer A. Jarrett
IPO Date
2026-03-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$24.46
Prev. Close
$24.21
Day Low
$24.44
Day High
$26.44
52W Low
$2.45
52W High
$38.33
Market Cap
$1.62B
Volume
0.12M
| -0.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -118.6% | -100.3% | 0.01 | 6.31 | -0.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -99.8% | -84.2% | 0.01 | 5.75 | -0.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -44.1% | -42.3% | 0.01 | 24.23 | -1.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -21.1% | -20.3% | 0.01 | 30.42 | -9.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -75.3% | -64.5% | 0.01 | 7.07 | -10.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -51.8% | -45.2% | 0.00 | 7.87 | -24.0 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -47.0% | -29.2% | 0.21 | 3.73 | -0.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -35.8% | -25.1% | 0.15 | 4.39 | -0.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -20.5% | -16.5% | 0.12 | 8.64 | -0.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -46.6% | -39.3% | 0.10 | 14.07 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -18.5% | -16.6% | 0.00 | 8.68 | -0.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -22.6% | -19.6% | 0.00 | 6.79 | -0.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -19.5% | -16.9% | 0.01 | 7.07 | -0.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -20.0% | -16.9% | 0.01 | 6.31 | -0.8 |